Atlas Venture Opportunity Fund II, L.P.

Insider Reports History

Location
Cambridge, MA
Signature
Atlas Venture Opportunity Fund II, L.P., By: Atlas Venture Associates Opportunity II, L.P., its general partner, By: Atlas Venture Associates Opportunity II, LLC, its general partner, By: /s/ Ommer Chohan, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Atlas Venture Opportunity Fund II, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dyne Therapeutics, Inc. 10%+ Owner Common Stock 1,608,785 $28,153,738 $17.50 12 Dec 2022 Indirect
Dyne Therapeutics, Inc. 10%+ Owner Common Stock 934,581 $16,355,168 $17.50 12 Dec 2022 Direct
Disc Medicine, Inc. 10%+ Owner Common Stock 218,326 $14,769,754 $67.65 29 Dec 2022 Direct
Day One Biopharmaceuticals, Inc. 10%+ Owner Common Stock 991,396 $11,589,419 $11.69 17 Jun 2022 Indirect
Korro Bio, Inc. 10%+ Owner Common Stock 195,074 $10,924,144 $56.00 22 Apr 2024 Direct
Day One Biopharmaceuticals, Inc. 10%+ Owner Common Stock 766,667 $8,962,337 $11.69 17 Jun 2022 Direct

Insider Reports Filed by Atlas Venture Opportunity Fund II, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KRRO Korro Bio, Inc. 22 Apr 2024 1 +$999,992 4 10%+ Owner 23 Apr 2024, 17:23
KRRO Korro Bio, Inc. 03 Nov 2023 0 $0 3 10%+ Owner 07 Nov 2023, 21:05
IRON Disc Medicine, Inc. 29 Dec 2022 0 $0 3 10%+ Owner 03 Jan 2023, 20:21
DYN Dyne Therapeutics, Inc. 12 Dec 2022 1 +$10,000,017 4 10%+ Owner 14 Dec 2022, 15:55
DAWN Day One Biopharmaceuticals, Inc. 17 Jun 2022 1 +$11,500,005 4 10%+ Owner 22 Jun 2022, 17:09